ABCAM Plc PDMR Shareholding

Date : 07/02/2012 @ 2:00AM
Source : UK Regulatory (RNS & others)
Stock : Abcam (ABC)
Quote : 1271.0  2.0 (0.16%) @ 8:26AM
Abcam share price Chart

ABCAM Plc PDMR Shareholding

Abcam (LSE:ABC)
Historical Stock Chart

5 Years : From Mar 2013 to Mar 2018

Click Here for more Abcam Charts.


RNS Number : 5777G


02 July 2012

 For immediate release   2 July 2012 


("Abcam" or "the Company")

PDMR dealing

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of protein research tools, announces that following completion of three years of continued employment since the award of Matching Shares under the Share Incentive Plan, the risk of forfeiture attached to these shares has now been removed, resulting in an increase in the beneficial holding of the following PDMR:

 Name                Matching Shares   Date of transfer   Total subsequent   Percentage 
                     now transferred      to beneficial         beneficial     of share 
                       to beneficial          ownership            holding      capital 
-----------------  -----------------  -----------------  -----------------  ----------- 
 Philippe Cotrel                  90       30 June 2012              7,028       0.004% 
-----------------  -----------------  -----------------  -----------------  ----------- 

For further information please contact:

 Abcam                                   + 44 (0) 1223 696 000 
 Jeff Iliffe, Chief Financial Officer 
 Numis Securities - Nominated Adviser 
  & Joint Broker                         + 44 (0) 20 7260 1000 
 Michael Meade - Nominated Adviser 
 James Black - Corporate Broking 
 Peel Hunt LLP - Joint Broker            + 44 (0) 20 7418 8900 
 Andy Crossley - Corporate Broking 
 Buchanan                                + 44 (0) 20 7466 5000 
 Mark Court / Fiona Henson / Sophie 

Notes for editors:

About Abcam plc

Abcam is a producer and distributor of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level, which is essential in understanding health and disease.

Headquartered in Cambridge (UK), Abcam has subsidiary offices in Bristol (UK), Cambridge, MA (USA), Eugene, OR (USA), San Francisco, CA (USA), Tokyo (Japan), Hangzhou and Hong Kong (both in China), allowing it to serve a global customer base in over 85 countries. Abcam employs over 590 staff across its eight operating companies.

Abcam now has an online catalogue of over 92,000 products sourced from over 300 suppliers. The catalogue includes a growing range of non-primary antibody products such as secondaries, proteins, peptides, lysates, immunoassays and other kits. Products are available for life science research and distributed to academic and commercial users. A highly developed eCommerce platform, which includes regional websites for the Chinese and Japanese markets, allows customers to access up-to-date and detailed technical product data sheets at the Company's website

Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company's vision is to be the world's leading life science tools company.

This information is provided by RNS

The company news service from the London Stock Exchange



Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V:us D:20180319 12:44:04